Form 4: NeuroOne Medical Technologies Executive Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark Christianson, Business Development Director at NeuroOne Medical Technologies, disposed of 343 shares of common stock on June 30, 2024, to satisfy tax obligations.
Summary
- On June 30, 2024, Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp, disposed of 343 shares of common stock.
- The transaction was executed to cover tax obligations arising from an unspecified event.
- Following the transaction, Christianson directly owns 294,692 shares of NeuroOne Medical Technologies Corp.
- The shares were disposed of at a price of $0.8.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations, with no indication of positive or negative sentiment towards the company's prospects.
Industry Context
Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders. This filing indicates a standard transaction for covering tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.
Stakeholder Impact
- The disposal of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the transaction.
Key Dates
| Date | Description |
|---|---|
| 06/30/2024 | Date of transaction: Mark Christianson disposed of shares. |
| 07/02/2024 | Date of signature: Form 4 signed by Stephanie Swan, by Power of Attorney. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.